The specialty pharmacy uses the smart bottles for five specialty medications, in programs with four different pharmaceutical manufacturers. Averaged across all patients and programs from 2015 through today, AdhereTech has improved duration on therapy by 26%, fill rates by 9%, and dose-level adherence by 15%.
Medication adherence is one of the most important — and complex – issues in health care today. Unfortunately, adherence is often especially challenging for patients who take specialty medications. These classes of medications may be more difficult for patients to manage, as they typically involve detailed treatment regimens, frequent side effects, varying doses schedule, detailed refill processes, higher copays, and the need for additional patient support.
At Avella, the AdhereTech program continues to achieve stellar results for patients. One of the many benefits is that the program delivers additional support to patients or caregivers when it’s needed most, leading to a great patient experience. For example, in addition to sending intelligent reminders for missed doses, the system is able to determine if a patient may need additional care via proprietary data analysis that occurs on the backend. In such an event, the system sends a real-time alert directly to an Avella nurse, who can then review the information from AdhereTech. The nurse can then decide to contact the patient to provide additional care, at the exact moment it’s needed. Patients receive this full service at no additional cost, and patient feedback is overwhelmingly positive, with the average patient satisfaction rating at 4.7 out of 5.
All parties in health care benefit from this program. Payors and providers see patients with higher adherence and streamlined management of health issues, such as adverse events. Pharmaceutical manufacturers see improved refills and dispenses. Pharmacies are able to intervene with patients early on, saving time and outreach efforts in the future. And most importantly, patients receive an exceptional patient experience and targeted real-time care.
“The use of AdhereTech has been a strategic part of Avella’s overall efforts to increase medication adherence rates and improve health outcomes for our patients,” said Eric Sredzinski, executive vice president
of clinical affairs and quality assurance for Avella. “By improving our ability to provide targeted support right when each individual needs it, this technology has truly optimized our patient care practices.”